Literature DB >> 6365155

Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease.

R E Champlin, S A Feig, R S Sparkes, R P Galen.   

Abstract

Treatment of aplastic anaemia by bone marrow transplantation from a syngeneic (identical twin) donor has provided insights into the pathophysiology of the disease. We report from patients with severe anaemia who were treated by syngeneic bone marrow transplantation. None of the patients had sustained recovery of peripheral blood counts. All four received second transplants from the same twin donor after immunosuppressive conditioning treatment. Each had prompt recovery of haematopoiesis. A review of the literature indicates that failure of syngeneic bone marrow transplantation in patients with aplastic anaemia is not uncommon. These data indicate that aplastic anaemia may be caused by a mechanism other than an absence or intrinsic abnormality of haematopoietic stem cells in many patients.

Entities:  

Mesh:

Year:  1984        PMID: 6365155     DOI: 10.1111/j.1365-2141.1984.tb03975.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Immune-mediated aplastic anaemia.

Authors:  Lucien Corbeel
Journal:  Eur J Pediatr       Date:  2005-11       Impact factor: 3.183

Review 2.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

Authors:  James L Gajewski; Viviana V Johnson; S Gerald Sandler; Antoine Sayegh; Thomas R Klumpp
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

3.  Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation.

Authors:  Sabine Gerull; Martin Stern; Jane Apperley; Dietrich Beelen; Lorentz Brinch; Donald Bunjes; Andrew Butler; Arnold Ganser; Ardeshir Ghavamzadeh; Mickey B Koh; Mieczyslaw Komarnicki; Nicolaus Kröger; Johan Maertens; Alexei Maschan; Christina Peters; Montserrat Rovira; Henrik Sengeløv; Gerard Socié; Johanna Tischer; Rosi Oneto; Jakob Passweg; Judith Marsh
Journal:  Haematologica       Date:  2013-07-26       Impact factor: 9.941

4.  Growth kinetics and blast-colony forming cell binding capacity of aplastic anaemic stromal cells.

Authors:  Y el-Khatib; J Gidáli; I Fehér; A Poros; A Mód; S Hollán
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

5.  Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.

Authors:  C W Park; C H Han; C C Kim; D J Kim; H K Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.